All Professionals
Overview
Meiyi Li is an associate in the Corporate practice of Paul Hastings and is based in the firm’s Shanghai office. Ms. Li’s practice focuses on securities offerings, post-IPO compliance and other general corporate matters. Ms. Li is fluent in Mandarin, Cantonese and English.
Prior to joining Paul Hastings, Ms. Li worked in the Corporate Department of two leading international law firms with headquarters based in the U.S.
Education
- Columbia Law School, LL.M. 2023
- Nanjing University, LL.B., BSc in Finance, 2018
Representations
- Goldman Sachs and CICC as the joint sponsors, joint global coordinators and underwriters, UBS as the financial advisor and joint global coordinator and underwriter, together with other underwriters, on the US$1.5 billion global offering and dual primary listing of Li Auto Inc. (HKSE:2015) on the Main Board of the Hong Kong Stock Exchange.*
- Morgan Stanley and Jefferies as the joint sponsors, joint global coordinators and underwriters, Haitong International Securities as the joint global coordinator and underwriter, together with other underwriters, on the US$88 million global offering and listing of CANbridge Pharmaceuticals Inc. (HKSE:1228), a leading biopharmaceutical company with a focus on rare diseases and gene therapy, on the Main Board of the Hong Kong Stock Exchange.*
- Alphamab Oncology (HKSE:9966), a leading clinical-stage biopharmaceutical company in China, on its US$234 million global offering and listing on the Main Board of the Hong Kong Stock Exchange.*
- CanSino Biologics Inc. (HKSE:6185), a biotech leader specializing in vaccine products for human use in China, on its US$160.5 million global offering and listing on the Main Board of the Hong Kong Stock Exchange.*
- CICC, J.P. Morgan and Nomura as the joint sponsors, joint global coordinators and underwriters, together with other underwriters, on the US$195 million global offering and listing of Viva Biotech Holdings (HKSE:1873), a leading structure-based, integrated drug discovery platform, on the Main Board of the Hong Kong Stock Exchange.*
- Haidilao International Holding Ltd. (HKSE:6862), a globally leading and fast-growing Chinese cuisine restaurant brand, on its US$964 million global offering and listing on the Main Board of the Hong Kong Stock Exchange.*
- CMS and CSIC as the joint sponsors, joint global coordinators and underwriters, together with other underwriters, on the US$126 million global offering and listing of Strawbear Entertainment Group (HKSE:2125), a major drama series producer and distributor in the PRC covering the investment, development, production and distribution of TV series and web series, on the Main Board of the Hong Kong Stock Exchange.*
- Yum China Holdings, Inc. (HKSE:9987; NYSE: YUMC), the largest restaurant company in China, on its US$2.2 billion global offering and secondary listing on the Main Board of the Hong Kong Stock Exchange. Its flagship brands include KFC and Pizza Hut, as well as emerging brands such as Little Sheep, Huang Ji Huang, COFFii & JOY, East Dawning, Taco Bell and Lavazza.*
- Rizhao Port Jurong Co., Ltd. (HKSE:6117), the largest port for grain and woodchip imports in China, on its US$69.7 million global offering and listing on the Main Board of the Hong Kong Stock Exchange.*
- Huatai and Credit Suisse as the joint sponsors, joint global coordinators and underwriters, on the global offering and listing of China Youran Dairy Group Limited (HKSE:9858), a leader in China’s upstream dairy market with an all-round business extending from breading, feed to raw milk production.*
* including projects involved in prior to joining Paul Hastings